New York Medical Cannabis Providers Sue State to Block Program Expansion

etain bloomfield industries pharmannis vireo health

With New York on the verge of adding five additional license holders, four of the five existing operators in the state’s medical cannabis program have filed a suit against the Department of Health, according to the Times Union. Bloomfield Industries, owned by MedMen, Etain, PharmaCann and Vireo Health argues that the market doesn’t have enough demand to support the existing providers. Columbia Care is not party to the litigation.

The total number of registered patients in New York is less than 18,000, but half of the first-time purchasers never repeat a purchase. Fewer than 1000 doctors and other medical providers have been approved to certify patients. Recently, the program added chronic pain as a qualifying condition, a move that could help drive growth.

Read Matthew Hamilton’s “NY medical marijuana companies sue over state’s plan to expand program”:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter